A.R.T. Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-20,075
Closed -$457K – 773
2019
Q4
$457K Buy
+20,075
New +$335K 0.02% 894
2019
Q3
– Sell
-27,875
Closed -$418K – 1676
2019
Q2
$418K Buy
27,875
+4,500
+19% +$78.5K 0.02% 818
2019
Q1
$410K Buy
23,375
+13,300
+132% +$210K 0.02% 814
2018
Q4
$149K Buy
+10,075
New +$167K 0.01% 1115
2018
Q3
– Sell
-24,156
Closed -$474K – 1640
2018
Q2
$474K Sell
24,156
-74,388
-75% -$1.41M 0.02% 944
2018
Q1
$1.85M Buy
98,544
+80,299
+440% +$1.31M 0.07% 415
2017
Q4
$190K Buy
18,245
+14,375
+371% +$143K 0.01% 1179
2017
Q3
$27K Sell
3,870
-24,341
-86% -$111K ﹤0.01% 1285
2017
Q2
$214K Sell
28,211
-14,175
-33% -$106K 0.01% 1134
2017
Q1
$339K Buy
+42,386
New +$285K 0.02% 960
2016
Q2
– Sell
-3,500
Closed -$103K – 1583
2016
Q1
$103K Buy
+3,500
New +$105K ﹤0.01% 1253

Other funds holding RCKT

A.R.T. Advisors's RCKT Position: Q1 2020 in Review

A.R.T. Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q1 2020, closing a stake of 20,075 shares — an estimated $457K sold.

A.R.T. Advisors first reported a position in RCKT in Q1 2016 and held it in 11 quarters. The position peaked at $1.85M in Q1 2018. 107 funds tracked by Wall St. Rank hold RCKT as of Q1 2020.

  • A.R.T. Advisors reported no remaining Rocket Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 20,075 Rocket Pharmaceuticals shares in Q1 2020, an estimated $457K.
  • A.R.T. Advisors first reported a position in Rocket Pharmaceuticals in Q1 2016 and held it in 11 quarters.
  • A.R.T. Advisors's Rocket Pharmaceuticals position peaked at $1.85M in Q1 2018.
  • 107 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.